Deferoxamine-d7 Trifluoroacetic Acid Salt (Major)
CAS: 162442-10-6
Rif. TR-D228982
5mg | 3.191,00 € | ||
500µg | 429,00 € |
Informazioni sul prodotto
- N1-(5-Aminopentyl)-N1-hydroxy-N4-[5-[[4-[[5-(acetylhydroxyamino)pentyl]amino]-1,4-dioxobutyl]hydroxyamino]pentyl]butanediamide-d7 Trifluoroacetic Acid Salt
- N-[5-[3-[(5-Aminopentyl)hydroxycarbamoyl]propionamido]pentyl]-3-[[5-(N-hydroxyacetamido)pentyl]carbamoyl]propionohydroxamic Acid-d7 Trifluoroacetic Acid Salt
- Ba 33112-d7
- DFOM-d7
- DFX-d7 Trifluoroacetic Acid Salt
- Deferoxamine B-d7 Trifluoroacetic Acid Salt
- Deferoxamine-d7 Trifluoroacetic Acid Salt
- Deferrioxamine B-d7 Trifluoroacetic Acid Salt
- Desferal-d7 Trifluoroacetic Acid Salt
- Desferrioxamine B-d7 Trifluoroacetic Acid Salt
- Vedi altri sinonimi
- Desferrioxamine-d7 Trifluoroacetic Acid Salt
- NSC 644468-d7 Trifluoroacetic Acid Salt
Applications Deferoxamine-d7 Trifluoroacetic Acid Salt, is labelled Deferoxamine Trifluoroacetic Acid Salt (D228981), an iron chelating agent used in therapy for patients with sickle cell diseases and iron overload. Studies suggest that it can exert potential antioxidant neuroprotective effects in stroke patients.
References Inati, A. et al.: Am. J. Hematol., 85, 782 (2010); Selim, M.: Translat. Stroke Res., 1, 35 (2010); Cappellini, M.D. et al.: Hemoblobin, 33, 258 (2009)
Proprietà chimiche
Richiesta tecnica su: TR-D228982 Deferoxamine-d7 Trifluoroacetic Acid Salt (Major)
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.